Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.

BACKGROUND & AIMS Intrahepatic cholangiocarcinoma (ICC) is a significant public health problem in East Asia, where it is strongly associated with chronic infection by the food-borne parasite Opisthorchis viverrini (OV). We report the first comprehensive miRNA expression profiling by microarray of the most common histologic grades and subtypes of ICC: well differentiated, moderately differentiated, and papillary ICC. METHODS MicroRNA expression profiles from FFPE were compared among the following: ICC tumour tissue (n = 16), non-tumour tissue distally macrodissected from the same ICC tumour block (n = 15), and normal tissue (n = 13) from individuals undergoing gastric bypass surgery. A panel of deregulated miRNAs was validated by qPCR. RESULTS Each histologic grade and subtype of ICC displayed a distinct miRNA profile, with no cohort of miRNAs emerging as commonly deregulated. Moderately differentiated ICC showed the greatest miRNA deregulation in quantity and magnitude, followed by the papillary subtype, and then well differentiated ICC. Moreover, when ICC tumour tissues were compared to adjacent non-tumour tissue, similar miRNA dysregulation profiles were observed. CONCLUSIONS We show that common histologic grades and subtypes of ICC have distinct miRNA profiles. As histological grade and subtypes are associated with ICC aggressiveness, these profiles could be used to enhance the early detection and improve the personalised treatment for ICC. These findings also suggest the involvement of specific miRNAs during ICC tumour progression and differentiation. We plan to use these insights to (a) detect these profiles in circulation and (b) conduct functional analyses to decipher the roles of miRNAs in ICC tumour differentiation.

[1]  A. Loukas,et al.  Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. , 2011, Acta tropica.

[2]  T Nakajima,et al.  A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. , 1988, Human pathology.

[3]  Krista A. Zanetti,et al.  Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.

[4]  Yasunori Sato,et al.  Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  M. Gazouli,et al.  Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance , 2013, Molecular carcinogenesis.

[6]  Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma , 2014, Journal of Translational Medicine.

[7]  Kazuhiko Hayashi,et al.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.

[8]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[9]  G. Gores,et al.  Pathogenesis, diagnosis, and management of cholangiocarcinoma. , 2013, Gastroenterology.

[10]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[11]  H. Vainio,et al.  Working group report on schistosomes, liver flukes and Helicobacter pylori. Meeting held at IARC, LYON, 7–14 june 1994 , 1995, International journal of cancer.

[12]  C. Stephan,et al.  Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. , 2010, Clinical chemistry.

[13]  T. Su,et al.  Identification of serum microRNAs as diagnostic and prognostic biomarkers for acute pancreatitis. , 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[14]  T. Patel,et al.  MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors , 2008, Hepatology.

[15]  C. Ong,et al.  Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis , 2013, Tumor Biology.

[16]  B. Sripa.  Pathobiology of opisthorchiasis: an update. , 2003, Acta tropica.

[17]  Susan Hutfless,et al.  Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis , 2014, Hepatology.

[18]  日本肝癌研究会.  General rules for the clinical and pathological study of primary liver cancer , 2010 .

[19]  M. Tewari,et al.  MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.

[20]  Banchob Sripa,et al.  Liver Fluke Induces Cholangiocarcinoma , 2007, PLoS medicine.

[21]  Jing Xu,et al.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. , 2010, World journal of hepatology.

[22]  Wojciech Fendler,et al.  Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report , 2014, Molecular Biology Reports.

[23]  Z. Dong,et al.  Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma , 2014, Tumor Biology.

[24]  Hsien-Da Huang,et al.  microRNA: a master regulator of cellular processes for bioengineering systems. , 2010, Annual review of biomedical engineering.

[25]  Jing Chen,et al.  MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing , 2011, PloS one.

[26]  K. Weinbren,et al.  Pathological aspects of cholangiocarcinoma , 1983, The Journal of pathology.

[27]  D. Parkin,et al.  Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[28]  D. Hawke,et al.  Molecular characterization of exosome-like vesicles from breast cancer cells , 2014, BMC Cancer.

[29]  J. Utzinger,et al.  Update on the diagnosis and treatment of food-borne trematode infections , 2010, Current opinion in infectious diseases.

[30]  M. Mayr,et al.  MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[31]  F. Cavalli.  Cancer in the developing world: can we avoid the disaster? , 2006, Nature Clinical Practice Oncology.

[32]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[33]  Peng-jun Zhang,et al.  Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.

[34]  Y. Mizuguchi,et al.  MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. , 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[35]  Le Yu,et al.  The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. , 2009, Journal of hepatology.